Zenith Drugs Ltd
ZENITHDRUGZenith Drugs Ltd
ZENITHDRUGHealth CarePharmaceuticals
SmallcapWith a market cap of ₹153 cr, stock is ranked 2,561
High RiskStock is 5.83x as volatile as Nifty
90.050.78% (+0.70)
90.050.78% (+0.70)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 8.88 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Zenith Drugs is an India-based pharmaceutical manufacturing and trading company.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
41.74
1Y Return
49.80%
Buy Reco %
67.65
Zydus Lifesciences Ltd
PE Ratio
31.44
1Y Return
93.63%
Buy Reco %
46.43
Cipla Ltd
PE Ratio
29.39
1Y Return
40.39%
Buy Reco %
75.00
Dr Reddy's Laboratories Ltd
PE Ratio
20.46
1Y Return
25.16%
Buy Reco %
40.74
Torrent Pharmaceuticals Ltd
PE Ratio
63.04
1Y Return
56.55%
Buy Reco %
78.57
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Earnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
---|---|---|---|---|---|---|---|---|
Total Revenue | 92.67 | 115.70 | 133.90 | — | ||||
Raw Materials | 49.14 | 47.92 | 116.16 | — | ||||
Power & Fuel Cost | 0.00 | 0.00 | ||||||
Employee Cost | 2.84 | 3.86 | ||||||
Selling & Administrative Expenses | 6.53 | 12.01 | ||||||
Operating & Other expenses | 26.19 | 40.74 | ||||||
EBITDA | 7.97 | 11.17 | 17.74 | — | ||||
Depreciation/Amortization | 1.33 | 1.30 | 1.30 | — | ||||
PBIT | 6.64 | 9.87 | 16.44 | — | ||||
Interest & Other Items | 2.24 | 2.65 | 3.00 | — | ||||
PBT | 4.40 | 7.22 | 13.44 | — | ||||
Taxes & Other Items | 1.27 | 2.06 | 3.84 | — | ||||
Net Income | 3.13 | 5.16 | 9.60 | — | ||||
EPS | 78.25 | 129.00 | 6.91 | — | ||||
DPS | 0.00 | — | 0.00 | — | ||||
Payout ratio | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticalsCompare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Zenith Drugs Ltd | 15.96 | 8.88 | — |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare ZENITHDRUG with any stock or ETFCompare ZENITHDRUG with any stock or ETF
ZENITHDRUG
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Feb 2024
Mar 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ZENITHDRUG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 30.02%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant